TheraTox® is a specialized treatment designed to address a variety of pain conditions through the use of small amounts of FDA-approved neuromodulators, such as Botox. This technique involves the identification of localized trigger spots, hydration to the affected area, and therapeutic dry needling. By mediating pain receptors and reducing inflammation, TheraTox® offers significant relief from pain. The neuromodulator works by blocking the calcitonin gene-related peptide, which is responsible for causing inflammation and pain in the nerves. This method has been widely used in medical practices for its effectiveness in providing long-lasting pain relief from months to years.

Good candidates for TheraTox® have not responded well to other treatments for chronic pain conditions. Before undergoing treatment, a thorough medical evaluation is conducted to determine the suitability of TheraTox® for each patient. Individuals’ pain points and medical histories are taken into consideration when tailoring their treatment.

The process of TheraTox® treatment begins with the identification of localized trigger spots. Once identified, these areas are treated with hydration and therapeutic dry needling to prepare the tissue. The neuromodulator is injected into the target areas to mediate pain receptors and reduce inflammation. Patients can expect a reduction in pain shortly after the treatment, with full effects typically noticeable within a few days. For many, the pain relief provided by TheraTox® facilitates a return to normal activities with reduced discomfort, resulting in significant improvements in quality of life.

Kim Suvak Warden, NP is exclusively trained and licensed to offer this treatment for Klinic patients only.